Evidence map›Paper›PMID 39050853›Full record

ArticleFrontiers in immunology2024

Development of a subunit vaccine against the cholangiocarcinoma causing

Mohibullah Shah, Farva Sitara, Asifa Sarfraz, Muhammad Shehroz, Tehreem Ul Wara, Asia Perveen, Najeeb Ullah, Aqal Zaman, Umar Nishan, Sarfraz Ahmed and 3 more

Erratum issuedAbstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Mohibullah Shah *Department of Biochemistry, Bahauddin Zakariya University, Multan, Pakistan.
Farva Sitara *Department of Biochemistry, Bahauddin Zakariya University, Multan, Pakistan.
Asifa SarfrazDepartment of Biochemistry, Bahauddin Zakariya University, Multan, Pakistan.
Muhammad ShehrozDepartment of Bioinformatics, Kohsar University Murree, Murree, Pakistan.
Tehreem Ul WaraDepartment of Biochemistry, Bahauddin Zakariya University, Multan, Pakistan.
Asia PerveenDepartment of Biochemistry, Bahauddin Zakariya University, Multan, Pakistan.
Najeeb UllahDepartment of Biochemistry, Bahauddin Zakariya University, Multan, Pakistan.
Aqal ZamanDepartment of Microbiology & Molecular Genetics, Bahauddin Zakariya University, Multan, Pakistan.
Umar NishanDepartment of Chemistry, Kohat University of Science & Technology, Kohat, Pakistan.
Sarfraz AhmedWellman Center for Photomedicine, Harvard Medical School, Massachusetts General Hospital, Boston, MA, United States.
Riaz UllahDepartment of Pharmacognosy, College of Pharmacy, King Saud University Riyadh, Riyadh, Saudi Arabia.
Essam A AliDepartment of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Suvash Chandra OjhaDepartment of Infectious Diseases, The Affiliated Hospital of Southwest Medical University, Luzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antigens, HelminthBile Duct NeoplasmsCholangiocarcinomaOpisthorchiasisOpisthorchisVaccines, SubunitAnimalsComputational BiologyEpitopes, B-LymphocyteEpitopes, T-LymphocyteHelminth ProteinsHumansMolecular Docking SimulationToll-Like Receptor 2Toll-Like Receptor 4Vaccine DevelopmentAntigens, HelminthEpitopes, B-LymphocyteEpitopes, T-LymphocyteHelminth ProteinsToll-Like Receptor 2Toll-Like Receptor 4Vaccines, SubunitcholangiocarcinomaepitopeOpisthorchis viverriniparasite; immunoinformatics-based vaccine designingvaccine

Identifiers

PMID39050853
PMCPMC11266093

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.